BioRem (CVE:BRM) Sets New 52-Week High – Time to Buy?

BioRem Inc. (CVE:BRM)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as C$3.45 and last traded at C$3.35, with a volume of 141939 shares traded. The stock had previously closed at C$3.22.

Analyst Upgrades and Downgrades

Separately, Cormark raised shares of BioRem to a “moderate buy” rating in a research report on Tuesday, December 17th.

BioRem Price Performance

The company has a current ratio of 1.57, a quick ratio of 1.08 and a debt-to-equity ratio of 48.97. The business’s fifty day moving average is C$3.01 and its 200 day moving average is C$2.53. The company has a market cap of C$48.20 million, a P/E ratio of 14.62 and a beta of 0.85.

Insider Buying and Selling

In other BioRem news, Director Derek Webb sold 120,000 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is currently owned by insiders.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.